Prospective observational study of anti-PD-L1 antibody drug atezolizumab for non small cell lung cancer
Not Applicable
Recruiting
- Conditions
- non small cell lung cancer
- Registration Number
- JPRN-UMIN000035616
- Lead Sponsor
- Second division, Depertment of Internal Medicine, Hamamatsu University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with autoimmune diseases or recurrent autoimmune disease 2. Patient with interstitial pneumonia 3. Patients with serious complications 4. Patients with difficult-to-control central nervous lesions
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method